These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2007537)

  • 1. Well-differentiated serous ovarian carcinoma presenting as a breast mass: a case report and flow cytometric DNA study.
    Frauenhoffer EE; Ro JY; Silva EG; el-Naggar A
    Int J Gynecol Pathol; 1991; 10(1):79-87. PubMed ID: 2007537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
    Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
    Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
    Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
    J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases.
    Raju U; Fine G; Greenawald KA; Ohorodnik JM
    Hum Pathol; 1989 May; 20(5):426-36. PubMed ID: 2707793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.
    Karlan BY; Baldwin RL; Lopez-Luevanos E; Raffel LJ; Barbuto D; Narod S; Platt LD
    Am J Obstet Gynecol; 1999 Apr; 180(4):917-28. PubMed ID: 10203660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serous surface papillary carcinoma of the ovary: a clinicopathologic study of 16 cases.
    Gooneratne S; Sassone M; Blaustein A; Talerman A
    Int J Gynecol Pathol; 1982; 1(3):258-69. PubMed ID: 7185762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemically detected p53 and HER-2/neu expression and nuclear DNA content in familial epithelial ovarian carcinomas.
    Auranen A; Grénman S; Kleml PJ
    Cancer; 1997 Jun; 79(11):2147-53. PubMed ID: 9179061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
    Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
    World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
    Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
    Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance.
    Kimball RE; Schlaerth JB; Kute TE; Schlaerth AC; Santoso J; Ballon SC; Spirtos NM
    Am J Obstet Gynecol; 1997 Jun; 176(6):1319-26; discussion 1326-7. PubMed ID: 9215191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinoma metastatic to the breast.
    Wadhwa J; Dawar R; Kumar L
    Clin Oncol (R Coll Radiol); 1999; 11(6):419-21. PubMed ID: 10663336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
    Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraluminal crystalloids in struma ovarii. Immunohistochemical, DNA flow cytometric, and ultrastructural study.
    Ro JY; Sahin AA; el-Naggar AK; Ordonez NG; Mackay B; Llamas LL; Ayala AG
    Arch Pathol Lab Med; 1991 Feb; 115(2):145-9. PubMed ID: 1992980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral metastatic carcinoma of the breast from primary ovarian cancer.
    Ozsaran AA; Dikmen Y; Terek MC; Ulukus M; Ozdemir N; Orgüc S; Erhan Y
    Arch Gynecol Obstet; 2000 Nov; 264(3):166-7. PubMed ID: 11129521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian carcinoma metastatic to the breast.
    Cormio G; di Vagno G; Melilli GA; Loverro G; Cramarossa D; Selvaggi L
    Gynecol Obstet Invest; 2001; 52(1):73-4. PubMed ID: 11549870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.